APA

Tam C. S., Abruzzo L. V., Lin K. I., Cortes J., Lynn A., Keating M. J., Thomas D. A., Pierce S., Kantarjian H. & Verstovsek S. (20090602). The role of cytogenetic abnormalities as a prognostic marker in primary myelofibrosis: applicability at the time of diagnosis and later during disease course. : Blood.

Chicago

Tam Constantine S, Abruzzo Lynne V, Lin Katherine I, Cortes Jorge, Lynn Alice, Keating Michael J, Thomas Deborah A, Pierce Sherry, Kantarjian Hagop and Verstovsek Srdan. 20090602. The role of cytogenetic abnormalities as a prognostic marker in primary myelofibrosis: applicability at the time of diagnosis and later during disease course. : Blood.

Harvard

Tam C. S., Abruzzo L. V., Lin K. I., Cortes J., Lynn A., Keating M. J., Thomas D. A., Pierce S., Kantarjian H. and Verstovsek S. (20090602). The role of cytogenetic abnormalities as a prognostic marker in primary myelofibrosis: applicability at the time of diagnosis and later during disease course. : Blood.

MLA

Tam Constantine S, Abruzzo Lynne V, Lin Katherine I, Cortes Jorge, Lynn Alice, Keating Michael J, Thomas Deborah A, Pierce Sherry, Kantarjian Hagop and Verstovsek Srdan. The role of cytogenetic abnormalities as a prognostic marker in primary myelofibrosis: applicability at the time of diagnosis and later during disease course. : Blood. 20090602.